Skip to main content
Signal8

TG THERAPEUTICS, INC. (TGTX)

Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solutions. The company's focus areas specifically include B-cell related cancers (malignancies) and various autoimmune disorders. Among its significant investigational therapeutic candidates is Ublituximab, a distinctive glycoengineered monoclonal antibody currently undergoing evaluation. It targets B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and the relapsing forms of multiple sclerosis. Another compound in its pipeline is Umbralisib, an orally administered inhibitor designed to block PI3K-delta and CK1-epsilon enzymes. This treatment is being investigated for its effectiveness against CLL, marginal zone lymphoma, and follicular lymphoma. TG Therapeutics is also developing Cosibelimab, an IgG1 human monoclonal antibody that functions by binding to programmed death-ligand 1 (PD-L1) and subsequently preventing its interaction with PD-1 and B7.1 receptors. Furthermore, the company is advancing TG-1701, an oral, covalently-bound Bruton's tyrosine kinase (BTK) inhibitor, notably more selective for BTK compared to ibrutinib in laboratory screenings. Completing this clinical-stage portfolio is TG-1801, a bispecific antibody engineered to simultaneously target CD47 and CD19. Beyond its clinical-stage assets, the company possesses various licensed preclinical programs, including those addressing BET, interleukin-1 receptor associated kinase-4, and GITR. To enhance its research and development capabilities, TG Therapeutics has forged collaboration agreements with entities such as Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company also maintains strategic alliances with partners including LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, Ildong Pharmaceutical Co. Ltd., and Rhizen Pharmaceuticals, S A.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

TG Therapeutics, Inc. logo

TG Therapeutics, Inc.

NASDAQ:TGTXHealthcare
+5.34%$61.18
AH$61.80+1.01%vs close
Mkt Cap$9.36B
Float147.28M
O/S153.07M
Vol
$ Vol
RVOL
Inst Own72.6%
SI20.1%
Earnings
Dilution
Financials Summary
Revenue$616.29M
Net Income$447.18M
Total Assets$1.06B
Free Cash Flow-$24.99M
Debt & Equity
Debt 29%
Equity 71%
Total Debt$260.73M
Total Equity$648.02M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:56.3Reverse split
    Apr 30, 201256.3 shares → 1
Balance Sheet Details
Assets$1.06B
Liabilities$415.23M
Accounts Receivable$305.63M
Accounts Payable$107.51M
Inventory$125.59M
PP&E (Net)$6.28M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997FY 1996
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-31
Revenue$616.29M$329M$233.66M$2.79M$6.69M$152K$152K$152K$152K$152K$152K$152K$152K$19K$0$0$0$0$0$0$0$0$0$500K$2.71M$5.36M$1.2M$3M$100K$100K
YoY Growth87.3%40.8%8290.0%-58.4%4300.7%0.0%0.0%-0.3%0.0%0.0%0.0%0.0%700.0%-----------81.6%-49.4%346.6%-60.0%2900.0%0.0%-
Cost of Revenue$100.71M$38.49M$14.13M$265K$790K$0$0$88K$82K$63K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$2.08M$4.06M$800K-$200K-$100K$0
Gross Profit$515.57M$290.52M$219.53M$2.52M$5.9M$152K$152K$64K$70K$89K$152K$152K$152K$19K$0$0$0$0$0$0$0$0$0$500K$629K$1.3M$400K$3.2M$200K$100K
Gross Margin83.7%88.3%94.0%90.5%88.2%100.0%100.0%42.1%46.0%58.7%100.0%100.0%100.0%100.0%---------100.0%23.2%24.3%33.3%106.7%200.0%100.0%
Research and Development$160.22M$94.29M$76.19M$125.35M$222.58M$165.9M$154.18M$153.79M$96.89M$66.49M$43.45M$31.35M$12.62M$20.57M$327K$496K$40K$1.8M$8.54M$6.17M$17.07M$4.15M$1.72M$540K$887K$1.13M$1.1M$3M$2.6M$1.1M
Selling, General, and Administrative$232.03M$154.3M$122.71M$95.48M$128.09M$107.85M$15.03M$15.16M$16.33M$9.89M$15.63M$15.79M$6.66M$4.78M$555K$1.52M$1.73M$2.61M$3.61M$3.83M$2.29M$1.99M$1.79M$1.51M$2.85M$3.26M$1.9M$2.7M$2.8M$2.8M
Other$0$0$0$0$0$0$0$61K-$59K$393K$1.03M$815K$3.41M$1.93M$0$0$0$0$0$0$0$0$1.25M$0$0$76K$100K$200K$100K$0
Total Operating Expenses$392.25M$248.59M$198.9M$220.84M$350.67M$273.75M$169.21M$174.55M$118.86M$79.12M$63.33M$55.87M$20.32M$25.81M$882K$2.02M$1.77M$4.41M$12.14M$10M$19.36M$6.14M$4.76M$2.05M$3.74M$4.46M$3.1M$5.9M$5.5M$3.9M
Operating Income (EBIT)$123.32M$41.93M$20.63M-$218.32M-$344.77M-$273.59M-$169.06M-$174.4M-$118.71M-$78.97M-$63.18M-$55.72M-$22.97M-$26.9M-$882K-$2.02M-$1.77M-$4.41M-$12.14M-$10M-$19.36M-$6.14M-$4.76M-$1.55M-$3.11M-$3.16M-$2.7M-$2.7M-$5.3M-$3.8M
Operating Margin20.0%12.7%8.8%-7839.0%-5154.3%-179996.1%-111220.4%-114736.8%-77904.6%-51823.5%-41461.9%-36567.0%-15071.4%-141196.4%----------310.6%-114.6%-59.0%-225.0%-90.0%-5300.0%-3800.0%
Interest Expense$26.73M$24.03M$12.62M$10.19M$5.64M$6.33M$5.29M$1.73M$1.14M$0$973K$931K$953K$906K$7K$1.27M$548K$65K$476$2K$0$0$0$0$0$0$0$0$0$0
Interest Income$0$0$0$0$0$0$0$857K$294K$323K$175K$55K$31K$16K$0$548K$587K$459K$0$0$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)-$15.93M-$16.34M-$7.57M-$5.5M-$3.33M-$5.79M-$3.82M$918K$236K$716K$231K-$60K-$310K-$63K-$7K$3.36M-$522K$394K$112K-$1K$6K$71K-$2.46M-$540K$1.33M-$2.73M$0$0$200K$200K
Income Before Tax (EBT)$107.39M$25.59M$13.06M-$223.81M-$348.1M-$279.38M-$172.87M-$173.48M-$118.48M-$78.25M-$62.95M-$55.78M-$20.48M-$25.85M-$889K$1.35M-$2.83M-$4.66M-$12.03M-$10M-$19.35M-$6.07M-$7.22M-$1.56M-$1.78M-$5.9M$0$0-$5.1M-$3.6M
Income Tax Expense-$339.79M$2.21M$390K$0$0$0$0-$918K-$236K-$716K-$231K$60K-$2.49M$330K$0-$2.64M$1.02M-$144K-$112K-$305K-$216K-$247K$1.2M-$6K-$1.37M$2.64M-$300K$100K$100K$0
Net Income$447.18M$23.38M$12.67M-$223.81M-$348.1M-$279.38M-$172.87M-$173.48M-$118.48M-$78.25M-$62.95M-$55.78M-$20.48M-$18.07M-$853K$624K-$2.79M-$4.27M-$12.03M-$9.7M-$19.14M-$5.9M-$5.96M-$1.55M-$1.73M-$5.8M-$2.4M-$2.8M-$5.2M-$3.6M
Net Income Margin72.6%7.1%5.4%-8036.3%-5204.1%-183803.3%-113730.9%-114132.9%-77749.9%-51353.4%-41310.0%-36606.5%-13438.8%-94879.9%----------309.4%-64.0%-108.3%-200.0%-93.3%-5200.0%-3600.0%
Supplementary Data
EPS3.100.160.09-1.46-2.63-2.42-1.96-2.30-1.91-1.60-1.38-1.64-0.81-1.38-0.4415.68-111.24-170.00-497.55-453.62-1236.34-615.64-748.86-347.70-1528.59-13339.03-7017.54-8750.00-23853.21-17391.30
Diluted EPS2.770.150.09-1.46-2.63-2.42-1.96-2.30-1.91-1.60-1.38-1.64-0.81-1.38-0.4415.68-111.24-170.00-497.55-453.62-1236.34-615.64-748.86-347.70-1528.59-13339.03-7017.54-8750.00-23853.21-17391.30
Weighted Average OS144.32M145.32M141.96M135.41M132.22M115.33M88.37M75.47M62.07M49.04M45.65M34.07M25.41M13.11M1.93M39,77825,11125,11124,18321,37315,4829,5777,9604,4491,135435342320218207
EBITDA$134.36M$49.9M$26.1M-$213.11M-$341.97M-$272.68M-$167.3M-$173.39M-$118.39M-$78.91M-$63.16M-$55.72M-$19.52M-$24.95M-$882K$1.9M-$1.74M-$3.93M-$11.98M-$9.63M-$19.09M-$5.87M-$2.11M-$995K-$3.04M-$3.09M-$2.6M-$3M-$5.2M-$3.7M
EBITDA Margin21.8%15.2%11.2%-7651.9%-5112.4%-179393.4%-110067.1%-114075.0%-77695.8%-51782.0%-41451.7%-36564.4%-12812.8%-130969.0%----------199.1%-112.1%-57.6%-216.7%-100.0%-5200.0%-3700.0%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997FY 1996
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-31
Assets
Current Assets
Cash and Cash Equivalents$79.15M$179.89M$92.93M$102.3M$298.89M$553.44M$112.64M$41.96M$56.72M$25.03M$55.06M$55.71M$40.49M$16.46M$9.75M$479K$18K$106K$650K$3.03M$9.83M$906K$7.41M$116K$1.59M$2.66M$3.5M$5.8M$8.5M$2.3M
Short-Term Investments$62.82M$131.11M$124.58M$59.37M$15.88M$51.99M$27.8M$26.85M$28M$19.85M$22.17M$23.06M$4.95M$0$0$0$0$0$0$0$1.01M$4.51M$352K$0$0$0$0$0$0$0
Cash and Short-Term Investments$141.97M$311M$217.51M$161.68M$314.76M$605.43M$140.44M$68.81M$84.83M$44.97M$102.42M$78.86M$45.43M$16.46M$9.75M$479K$18K$106K$650K$3.03M$10.83M$5.42M$7.77M$116K$1.59M$2.66M$3.5M$5.8M$8.5M$2.3M
Accounts Receivable$305.63M$129.19M$51.09M$0$1.39M$0$0$95K$108K$84K$186K$86K$27K$0$0$244K$0$0$0$0$0$0$0$0$0$193K$300K$400K$0$0
Inventory$125.59M$110.46M$39.82M$0$0$0$0$9.69M$7.95M$5.59M-$16.04M$6.09M-$3.2M$0$0$4K$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$57.58M$15.72M$5.34M$2.36M$2.88M$1.08M$611K$344K$328K$216K$308K$174K$48K$29K$87K$142K$246K$730K$0$0$0$0$0$59K$0$0$0$100K$0$0
Total Current Assets$630.76M$566.36M$317.94M$168.27M$330.96M$611.74M$149.15M$79.03M$93.32M$50.86M$86.87M$85.22M$42.3M$18.48M$9.84M$869K$264K$874K$866K$3.29M$11.03M$5.46M$7.79M$175K$1.63M$2.88M$3.8M$6.3M$8.5M$2.3M
Long-Term Assets
Property, Plant & Equipment Net$6.28M$7.15M$8.14M$10.82M$11.07M$11.84M$11.81M$2.54M$2.68M$2.37M$47K$20K$6K$1K$0$3K$4K$9K$45K$84K$107K$119K$8K$56K$105K$227K$100K$300K$300K$100K
Goodwill$0$0$799K$799K$799K$799K$799K$799K$799K$799K$799K$799K$799K$799K$630K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$2.8M$5.44M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$59.14M$808K$1.28M$12.4M$35.53M$0$0$1.24M$587K$583K$25M-$22.8M$4.92M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$348M$0$0$0$0$0$0-$1.24M-$587K-$583K$0$22.8M$0$10.39M-$438.02M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$19.07M$3.37M$1.42M$1.27M$1.26M$1.26M$1.25M$1.24M$587K$748K$750K$712K$85K-$10.39M$438.02M$17.76M$98K$366K$71K$71K$71K$71K$0$20K$23K$70K$100K-$100K$0$0
Total Long-Term Assets$432.49M$11.33M$11.64M$25.3M$48.66M$13.9M$13.86M$4.58M$4.06M$3.92M$26.6M$1.53M$5.81M$3.6M$6.07M$17.77M$102K$375K$115K$154K$177K$190K$8K$76K$128K$297K$200K$200K$300K$100K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$1.06B$577.69M$329.59M$193.57M$379.63M$625.64M$163.01M$83.62M$97.38M$54.78M$113.47M$86.75M$48.11M$22.07M$15.91M$18.64M$366K$1.25M$981K$3.45M$11.21M$5.65M$7.8M$251K$1.76M$3.18M$4M$6.5M$8.8M$2.4M
Liabilities
Current Liabilities
Accounts Payable$107.51M$0$0$0$0$0$0$36.38M$25.88M$15.27M$9.35M$3.99M$4.76M$1.12M$667K$224K$215K$542K$1.28M$1.39M$1.62M$1.14M$549K$165K$509K$786K$500K$0$0$0
Short-Term Debt$1.04M$0$0$0$975K$22.18M$0$67K$128K$69K$212K$275K$678K$678K$878K$2.05M$1.27M$70K$0$0$0$0$0$806K$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0-$55.78M$0-$25.85M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$21.23M$11.41M$152K$0$0$0$0$152K$152K$152K$152K$152K$152K$152K$0$481K$258K$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$23.97M$78.11M$52.12M$51.62M$62.97M$63.71M$82.83M$0$0$0$0$0$190K$124K$0$535K$861K$0$0$0$0$0$0-$409K$0$0$0$700K$400K$300K
Total Current Liabilities$153.76M$90.68M$53.72M$53.2M$65.38M$87.55M$84.45M$38.85M$27.96M$16.88M$10.53M$5.12M$6.32M$2.22M$1.61M$3.29M$2.53M$1.49M$1.87M$1.94M$1.67M$1.2M$966K$578K$509K$2.08M$500K$700K$400K$300K
Long-Term Liabilities
Long-Term Debt$252.67M$244.43M$100.12M$71.14M$66.79M$7.72M$28.97M$0$0$0$0$0$65K$2.48M$3.29M$16.13M$431K$1.19M$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$8.81M$12.09M$6.02M$305K$457K$610K$762K$914K$1.07M$1.22M$1.37M$1.52M$1.68M$1.83M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$3.85M-$2.36M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities-$7.02M$0$0$0$0$0$0$19.81M$1.36M$816K$0$0$0$0$0$4.58M$4.19M$2.95M$0$0$0$0$0$0$0$0$100K-$100K$0$0
Total Long-Term Liabilities$261.47M$264.65M$115.36M$81.78M$77.09M$18.74M$39.95M$20.73M$2.43M$2.04M$1.37M$1.52M$1.74M$4.31M$4.66M$20.71M$4.62M$4.14M$1.28M$1.39M$1.62M$1.14M$549K$578K$509K$786K$100K-$100K$0$0
Other Liabilities$0$0$0$0$0$0$0$0$66.99M$35.87M$101.57M$80.1M$40.05M$0$0$0$0$0-$1.28M-$1.39M-$1.62M-$1.14M-$549K-$578K-$509K-$786K$0$0$0$0
Total Liabilities$415.23M$355.33M$169.09M$134.99M$142.48M$106.29M$124.4M$59.58M$97.38M$54.78M$113.47M$86.75M$48.11M$6.52M$6.27M$24M$7.15M$5.62M$1.87M$1.94M$1.67M$1.2M$966K$578K$509K$2.08M$600K$600K$400K$300K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$413$0$0$0$0$0$0$854$1K$521K$521K$521K$0$0$0$0
Common Stock$159K$156K$151K$146K$143K$141K$109K$84K$73K$57K$54K$45K$34K$26K$285K$121K$71K$71K$71K$60K$60K$28K$23K$17K$16K$6K$500K$0$0$0
Retained Earnings-$1.08B-$1.53B-$1.55B-$1.53B-$1.33B-$980.6M-$701.22M-$528.35M-$354.86M-$236.39M-$158.13M-$95.19M-$39.4M-$18.93M-$853K-$61.31M-$61.93M-$59.27M-$55M-$42.97M-$33.27M-$13.96M-$7.47M-$28.28M-$26.73M-$24.83M-$18.8M-$16.3M-$13.5M-$8.4M
Comprehensive Income & Other$0$0$0$0$0$0$0$0$0-$0$6$6$6$0$0-$36K-$32K-$27K-$181K-$160K$987$296K-$8K-$77K-$218-$218-$200K-$300K-$200K-$100K
Other Stockholders' Equity$1.73B$1.75B$1.71B$1.59B$1.57B$1.5B$739.72M$552.3M$421.78M$272.2M$259.65M$175.24M$79.42M$34.45M$10.19M$55.82M$55.08M$54.82M$54.04M$44.41M$42.75M$18.38M$14.28M$27.93M$27.96M$25.32M$21.7M$22.2M$21.9M$10.5M
Total Equity$648.02M$222.36M$160.5M$58.59M$237.15M$519.35M$38.62M$24.04M$66.99M$35.87M$101.57M$80.1M$40.05M$15.55M$9.62M-$5.36M-$6.78M-$4.38M-$891K$1.5M$9.54M$4.45M$6.83M-$327K$1.25M$496K$3.4M$5.9M$8.4M$2.1M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$12K$0$0$0$0$0$0$0$0$0$0$600K$0$0$0$0
Total Liabilities and Equity$1.06B$577.69M$329.59M$193.57M$379.63M$625.64M$163.01M$83.62M$164.37M$90.65M$215.05M$166.85M$88.17M$22.07M$15.9M$18.64M$366K$1.25M$981K$3.45M$11.21M$5.65M$7.8M$251K$1.76M$2.58M$4M$6.5M$8.8M$2.4M
Supplementary Data
Total Debt$260.73M$253.72M$110.8M$83.06M$79.05M$41.98M$40.8M$67K$128K$69K$212K$275K$742K$3.16M$4.88M$18.81M$1.94M$1.26M$0$0$0$0$0$800K$0$0$0$0$0$0
Net Debt$181.58M$73.83M$17.86M-$19.24M-$219.84M-$511.46M-$71.83M-$41.89M-$56.59M-$24.96M-$54.85M-$55.44M-$39.74M-$13.3M-$4.86M$18.33M$1.93M$1.15M-$650K-$3.03M-$9.83M-$906K-$7.41M$684K-$1.59M-$2.66M-$3.5M-$5.8M-$8.5M-$2.3M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997FY 1996
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-31
Operating Activities
Net Income$447.18M$23.38M$12.67M-$198.34M-$348.1M-$279.38M-$172.87M-$173.48M-$118.48M-$78.25M-$62.95M-$55.78M-$20.48M-$26.18M-$889K$624K-$2.79M-$4.27M-$12.03M-$9.7M-$19.14M-$5.9M-$5.96M-$1.55M-$1.73M-$5.8M-$2.4M-$2.8M-$5.2M-$3.6M
Depreciation & Amortization$244K$280K$423K$515K$494K$374K$282K$88K$82K$63K$15K$4K$1K$235$0$3K$6K$26K$48K$60K$54K$128K$189K$50K$66K$76K$100K$200K$100K$0
Deferred Income Tax-$348M$0$0$0$517K-$30K-$257K-$119K$61K$5.84B$5.84B$10.01M$10.01M$289K$0$353K$500K$250K-$1.68M$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$64.67M$42.54M$37.93M$19.18M$61.27M$80.29M$11.34M$12.89M$15.95M$7.51M$15.7M$21.11M$5.2M$3.42M$86K$217K$353K$464K$1.68M$0$0$0$0$0$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable-$176.44M-$78.09M-$51.09M$1.39M-$1.39M-$6K-$11K$14K-$25K$102K-$101K$0$0$0$0-$244K$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Inventory-$33.45M-$66.85M-$36.94M$0-$15.99M$6K$11K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$55.88M$0$192K-$11.01M$15.99M$11.63M-$4.79M$10.96M$11.02M$6.49M$5.47M-$603K$4.03M$596K$0$0-$327K-$737K-$224K$0$0$0$0$0$0$0$0$0$0$0
  Other Working Capital-$40.52M$35.65M$3.18M$7.97M-$10.83M-$31.39M$29.98M$27.76M$8.56M$2.28M-$3.4M-$5.44M$31K$110K$419K$440K$108K-$235K$221K$208K$1.04M$144K-$142K$52K-$2.04M$1.67M-$100K-$100K$100K-$600K
Total Working Capital Change-$194.54M-$109.3M-$84.66M-$1.65M-$12.22M-$19.76M$25.19M$27.76M$8.56M$8.77M$2.07M-$6.05M$4.07M$706K$419K$196K-$219K-$972K-$3K$208K$1.04M$144K-$142K$52K-$2.04M$1.67M-$100K-$100K$100K-$600K
Other Non-Cash Items$5.67M$2.58M$2.22M$4.11M$2.4M$4M$3.52M$3.94M$59K-$5.84B-$5.84B-$4.35M-$9.63M$16.58M$297K-$3.36M$1.1M$57K$1.76M$1.68M$11.8M-$67K$2.46M$13K-$764K$2.9M$100K$100K$900K$200K
Net Cash from Operating-$24.77M-$40.52M-$31.41M-$176.17M-$295.63M-$214.51M-$132.81M-$128.93M-$93.76M-$61.59M-$44.69M-$35.06M-$10.82M-$5.19M-$87K-$1.97M-$1.05M-$4.44M-$10.23M-$7.75M-$6.24M-$5.69M-$3.45M-$1.43M-$4.47M-$1.15M-$2.3M-$2.6M-$4.1M-$4M
Investing Activities
Capital Expenditures-$214K-$45K$0-$14K-$401K-$357K-$131K-$90K-$2K-$344K-$42K-$19K-$6K-$1K$0-$3K$0-$9K-$9K-$37K-$40K-$138K-$7K-$5K-$108K-$171K-$100K-$200K-$200K-$100K
Acquisitions$0$0$0$20M-$69K$24.15M$587K$0$0$0$0$0$0$0$10K$519K$0$0-$1.01M$0$7K$0-$33K$0$0$0$0$0$0$0
Purchases of Investments-$223.49M-$311.89M-$146.88M-$107.27M-$55.53M-$67.4M-$29.84M-$31.23M-$28.01M-$15.2M-$48.99M-$18.34M-$4.92M$0$0$0$0$0$1.01M$0$0-$5M$0$0$0-$147K$0$0$0$0
Sales of Investments$237.5M$310.9M$96.23M$87.28M$55.6M$43.25M$29.25M$32.5M$19.8M$42.09M$24.35M$0$0$0$0$0$0$0$1K$1.01M$3.5M$931K$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0-$20M$69K-$24.15M-$587K$1.27M-$8.21M$26.89M-$24.64M-$18.34M-$4.92M$0$0$0$0$0-$1K$0$0$0$200K$0$3M$0$0$0$0$0
Net Cash from Investing$13.8M-$1.04M-$50.65M-$20.01M-$332K-$24.51M-$718K$1.18M-$8.21M$26.55M-$24.69M-$18.36M-$4.93M-$1K$10K$517K$0-$9K-$9K$969K$3.47M-$4.21M$161K-$5K$2.89M-$318K-$100K-$200K-$200K-$100K
Financing Activities
Debt Repaid--$137.26M-$25M$975K-$40M--$29.99M----$678K-----$435K-$990K----$806K-$779K-----$200K
Common Stock Issuance$1.51M$0$46.3M$584K$2.22M$679.68M$175.02M$113.64M$131.52M$4.41M$67.76M$65.61M$37.65M$0$9.82M$2.16M$0$0$7.86M$0$12.35M$3.39M$9.79M$1.7M$1.94M$1.17M$0$100K$10.6M$1.5M
Common Stock Repurchases-$91.24M-$8.76M$0$0$0$0$0$0$0$0$0$0-$150K-$85K$0$0$0$0$0-$15K$0$0-$300$0-$617K-$512K$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0-$807-$987$0$0$0$0$0
Other Financing Activities$0$25K$1.41M$0-$800K$147K-$795K$0$0-$13K$963K$3.71M$0-$76K$0-$249K$527K$2.85M$0$0$0-$1K$0-$2.52M-$811K$0$0$0$0$0
Net Cash from Financing-$89.73M$128.53M$72.7M-$391K$41.42M$679.83M$204.21M$113.64M$133.66M$5.02M$68.72M$68.64M$39.78M$11.9M$9.82M$1.91M$962K$3.91M$7.86M-$15K$11.7M$3.39M$8.98M-$37K$511K$661K$0$100K$10.6M$1.3M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$100.7M$86.97M-$9.36M-$196.57M-$254.55M$440.81M$70.69M-$14.11M$31.69M-$30.03M-$652K$15.23M$24.03M$6.71M$9.75M$461K-$88K-$544K-$2.38M-$6.8M$8.92M-$6.51M$5.69M-$1.48M-$1.07M-$810K-$2.3M-$2.7M$6.3M-$2.8M
Supplementary Data
Operating Cash Flow-$24.77M-$40.52M-$31.41M-$176.17M-$295.63M-$214.51M-$132.81M-$128.93M-$93.76M-$61.59M-$44.69M-$35.06M-$10.82M-$5.19M-$87K-$1.97M-$1.05M-$4.44M-$10.23M-$7.75M-$6.24M-$5.69M-$3.45M-$1.43M-$4.47M-$1.15M-$2.3M-$2.6M-$4.1M-$4M
Capital Expenditure-$214K-$45K$0-$14K-$401K-$357K-$131K-$90K-$2K-$344K-$42K-$19K-$6K-$1K$0-$3K$0-$9K-$9K-$37K-$40K-$138K-$7K-$5K-$108K-$171K-$100K-$200K-$200K-$100K
Free Cash Flow-$24.99M-$40.56M-$31.41M-$176.18M-$296.04M-$214.86M-$132.94M-$129.01M-$93.77M-$61.94M-$44.73M-$35.08M-$10.83M-$5.19M-$87K-$1.97M-$1.05M-$4.45M-$10.24M-$7.79M-$6.28M-$5.83M-$3.46M-$1.44M-$4.58M-$1.32M-$2.4M-$2.8M-$4.3M-$4.1M
Cash at Beginning$181.19M$94.22M$103.58M$300.15M$554.7M$113.89M$43.2M$57.3M$25.03M$55.06M$55.71M$40.49M$16.46M$9.75M$0$18K$106K$650K$3.03M$9.83M$906K$7.41M$1.72M$1.59M$2.66M$3.47M$5.8M$8.5M$2.3M$5M
Cash at End$80.49M$181.19M$94.22M$103.58M$300.15M$554.7M$113.89M$43.2M$56.72M$25.03M$55.06M$55.71M$40.49M$16.46M$9.75M$479K$18K$106K$650K$3.03M$9.83M$906K$7.41M$116K$1.59M$2.66M$3.5M$5.8M$8.6M$2.2M